Business:
Treg Cell Therapy for Autoimmune Diseases
Drug notes:
KYV-201 RD autoimmune diseases
About:
Kyverna Therapeutics is engineering cell therapies for autoimmune and inflammatory diseases. Many autoimmune diseases lack optimal treatment for patients. Through the use of synthetic biology, immunology and cell engineering, Kyverna is using their SmarTcell platform to advance technologies to treat the cause of these diseases. Kyverna’s technologies include chimeric antigen receptor T cells designed to eliminate pathogenic cells in specific organs and tissues. Kyverna is also developing synthetic versions of Regulatory T cells to control immune homeostasis. Current therapies are in clinical trials for B-cell driven autoimmune diseases.
Sr. Director, Clinical Research Scientist Remote|1 day ago
Cloud Systems Administrator Emeryville, CA|2 days ago
Director, Process Development Emeryville, CA|9 days ago
Manager, Regulatory Affairs Emeryville, CA|16 days ago
Director, Quality Compliance and Risk Management Emeryville, CA|21 days ago
Director, Manufacturing Sciences and Technology (M... Emeryville, CA|22 days ago
Sr. Director, Technical Program Lead CMC Emeryville, CA|23 days ago
Director, Corporate Communications Emeryville, CA|35 days ago
Sr. Contracts Counsel (Director) Emeryville, CA|38 days ago
Senior Manager/Associate Director, Statistical Pro... Emeryville, CA|39 days ago
Manager, Quality Systems Emeryville, CA|100+ days ago
Senior Director, Biostatistics Emeryville, CA|100+ days ago